Caitriona Higgins
@Cathiggins7
Followers
185
Following
527
Media
14
Statuses
311
Passionate about quality improvement and patient and public involvement. Nurse and Patient Engagement Lead in the Cancer Directorate Beaumont Hospital
Dublin City, Ireland
Joined May 2011
Congratulations to our amazing UCAN Ireland members Miriam Staunton and Cynthia Cravo on becoming @eupatients Fellows 🎉 A wonderful achievement. We are so proud of you both👏❤️
2
6
18
How can we improve #CancerDetection in #PrimaryCare ? @PRiCAN_Research are seeking input from patients, carers, clinicians, academics & policymakers to help identify the top 10 research priorities 🧐 Anonymous responses. Take part here: https://t.co/TTzlR9uzkT… Pls share 🙏
0
2
6
Congratulations Heba Khalil, Quality Lead for the CUH/UCC Cancer Centre, presenting at the Third #CCI4EU @OECI_EEIG Capacity Building Conference in Madrid, showcasing innovation and collaboration in patient pathway development for improved cancer care.
0
5
17
T-1 day until #ESMO25! Delighted to serve as one of the #ESMOAmbassadors 🇮🇪 highlighting advances in lung cancer, immunotherapy, women in oncology, & career development through @myESMO #YOC
@myESMO @CancerCentreIre @IrishLungCancer @OncoAlert #LCSM
#ESMO25: Discover the latest #CancerResearch insights brought to you by #ESMOAmbassadors and join the conversation in #oncology. 🔗 https://t.co/YZZN0sQyBS
4
11
47
Collaboration, connection and continually improving the cancer #patientpathway. The third #CCI4EU capacity building conference provided the venue for it all. Well done @AislingHegarty2 and @Cathiggins7 on your presentations at this.
0
2
16
In the EUonQoL project, cancer patients and informal caregivers are not just consulted, they are co-researchers. A newly published paper explains how they’re recruited and trained.📄 Read the paper at : https://t.co/DOVDIo8PfR
0
1
3
Delighted to present episode 2 of @myESMO @Women4Oncology’s Diary of an Oncology Leader, with Chair of Thoracic Oncology @marinagarassino from @UofC Great insights on: - role of community in skill-building - self belief - thinking big ‘Don’t wait. Just start’ @OncoAlert #LCSM
A new Diary of an Oncology Leader video is out. In this episode, @marinagarassino shares her thoughts on her journey overseas, the founding of W4O Italy and the leadership lessons that shaped her path Watch now for inspiration 🔗 https://t.co/fPa5DEhLW0
#W4O #OncologyLeadership
2
12
44
Congratulations Dr @DavidOReilly2 , on his Young Investigator Award at @ASCO. Investigating if exhaled breath liquid biopsy can be used to predict early progression on chemo-immunotherapy for patients with advanced #nonsmallcelllungcancer
https://t.co/Ocsq4JG4Aa
beaumontrcsicancercentre.ie
Conquer Cancer Young Investigator Award, Cancer Research, Lung Cancer, Reserach, Medical Oncology, Awards, ASCO,
2
5
27
Congratulations to Lung Health Check study team member @DavidOReilly2 on receiving a well-deserved award at @ASCO! Proud to have such a talented fellow on the team. Kudos as well to his stellar supervisory team — @DrJNaidoo, @sinead_toomey, and Prof. Hennessy @CancerCentreIre!
3
4
19
Today is our annual cancer conference - a highlight event of the calendar. We are delighted to welcome all of our speakers and delegates interested in "Modernising the landscape of cancer care."
Welcome to those attending today's Beaumont RCSI @CancerCentreIre Conference. Today's event will focus on transforming cancer care through innovation and equity More➡️ https://t.co/QujCpDvlrE
0
4
10
The day has finally arrived! We are looking forward to hearing from a fantastic line up of speakers at our cancer conference today. #cancerconference #cancercare
@RCSI_Irl
0
2
17
On #InternationalClinicalTrialsDay our cancer clinical trials team are out and about on the oncology and haematology units today meeting with patients and staff, so if you have a question #justask #CRD2025 #cancertrialsireland
0
6
22
In the video below, Csaba Dégi, president of @EuropeanCancer, explains how the EUonQoL project can make #QualityofLife a priority in oncology across Europe. 🗣️ Watch now and learn why quality of life matters. 📽️
0
3
1
#Sunprotection is important all year round, with 11,000 new #skincancer cases in Ireland each year. The NCRI predict this will double by 2040. Well done to the skin cancer nursing team, who were out in force yesterday reminding us to be #sunsmart
1
2
8
DID YOU REGISTER -WE ARE ALMOST THERE! Clinical trials drive innovation in research and patient care across all therapeutic disciplines. Join us as we showcase our experts to celebrate International Clinical Trials day. https://t.co/M37Lzp8hAl 23rd May - 9am-1pm
eventbrite.ie
Celebrate International Clinical Trials Day with us at Beaumont RCSI on May 23, 2025 — featuring a lineup of speakers on clinical research.
0
2
5
This week is #worldimmunisationweek. To find out more about the important role of #HepatitisB and #HPV vaccination in cancer prevention click here
europeancancer.org
World Immunization Week 2025 (24–30 April) is a campaign led by the World Health Organization to highlight the life-saving power of vaccines. At the European Cancer Organisation, we are proud to...
0
2
3
Well done to @caitrionahiggins our PPI lead for speaking on behalf of her fellow co-researchers @euonqol general assembly on the principles that can be used to create true partnership between patient representatives and researchers @EUonQol_ @Nivel #patientsinvolved #PPI
0
2
14
This May, to celebrate International Clinical Trials Day, Beaumont and RCSI are hosting a conference showcasing the latest in surgical, radiotherapy, cancer and multi therapeutic area trials! Click to register https://t.co/RfpapOj16t?
#clinicaltrials #research #clinicalresearch
0
11
16
New paper in @JTOonline characterising MET tyrosine kinase domain (TKD) mtns in NSCLC - incidence 0.15% in >150,000pts - ~50% co-occur with a primary driver (eg KRAS, EGFR, ALK) - can occur as mech of acquired resistance to targeted tx @OncoAlert #LCSM
https://t.co/nd7ZbLfWE4
jto.org
MET tyrosine kinase domain (TKD) mutations have recently been characterized as de novo oncogenic drivers in NSCLC. Nevertheless, whether activating MET TKD mutations can confer resistance to targeted...
1
12
44
#BowelScreen is for everyone aged 59 to 70. Find out how to take part in BowelScreen, how it works, and how one test can help reduce the risk of developing bowel cancer over your lifetime. ➡️ https://t.co/Nda6o37OqF
#ChooseScreening #BowelCancerAwarenessMonth
0
3
9